Effects of a combination of bifidobacteria quadruple viable bacteria tablets and quadruple therapy on inflammatory response and Helicobacter pylori eradication rate in patients with Helicobacter pylori positive gastric ulcers

Bifidobacteria quadruple viable bacteria tablets plus quadruple therapy can improve the clinical symptoms, promote the clinical therapeutic effect and <i>Hp</i> eradication rate, improve the levels of gastrointestinal hormones and inflammatory factors, enhance the immune function, increase levels of beneficial bacteria and diminish the incidence of adverse reactions caused by quadruple therapy in patients suffered from <i>Hp</i>-positive gastric ulcer.